PR Hub

Astellas Pharma Inc.

Astellas Signs United Nations Global Compact


TOKYO, November 11, 2011 - Astellas Pharma Inc.
MORE..

Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for Overactive Bladder, in U.S. and Europe


STAINES, England, August 30, 2011 - Astellas Pharma Inc.
MORE..

Interim Data From Phase 2 Trial of AC220 Monotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia With FLT3-ITD Activating Mutations


LONDON, June 13, 2011 - Ambit Biosciences Corporation and Astellas Pharma Inc.
MORE..

First Presentations of European-Australian and North American Phase III Trials at European Association of Urology Congress


TOKYO, March 21, 2011 - Astellas Pharma Inc.
MORE..

Expansion of Territory for Eligard(R) in Asia, Middle East, Africa and CIS


TOKYO, January 17, 2011 - Astellas Pharma Inc.
MORE..
More News
Older News
S M T W T F S
23 24 25 26 27 28 29
30 31 1 2 3 4 5
6 7 8 9 10 11 12
Copyright© 2011 The Gaea Times